Beclomethasone dipropionate blunts allergen-induced early increase in urinary LTE4

European Journal of Clinical Investigation

Volumn 40, Issue 6, 2010, Pages 566-569

  Bartoli, Maria Laura ^a   Dente, Federico Lorenzo ^a   Bancalari, Lorenza ^b   Bacci, Elena ^a   Cianchetti, Silvana ^a   Di Franco, Antonella ^a   Vagaggini, Barbara ^a   Paggiaro, Pier Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Ospedale di Sarzana   (Italy)

Author keywords

Allergen challenge; Beclomethasone dipropionate; Late response; Urinary LTE4

Indexed keywords

BECLOMETASONE DIPROPIONATE; LEUKOTRIENE E4; PLACEBO;

ADULT; ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRICK TEST; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTECTION;

ADMINISTRATION, INHALATION; ADULT; ALLERGENS; ASTHMA; BECLOMETHASONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE E4; MALE; SPIROMETRY; TIME FACTORS; YOUNG ADULT;

EID: 77952626087     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02297.x     Document Type: Article

References (20)

1. Arshad SH. Bronchial allergen challenge: a model for chronic allergic asthma? Clin Exp Allergy 2000 30: 12 5.
2. O'Byrne PM, Gauvreau GM, Brannan JD. Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009 39: 181 192.
3. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodelling. J Allergy Clin Immunol 2003 111 (Suppl. 1 S18 34.
4. Manning PJ, Rokach J, Malo JL, Ethier D, Cartier A, Girard Y et al. Urinary leukotriene E4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990 86: 211 220.
5. Bancalari L, Conti I, Giannessi D, Lazzerini G, Dente FL, De Caterina R et al. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects. Allergy 1999 54: 1278 1285.
6. O'Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998 28: 1309 1312.
7. Dworski R, Fitzgerald GA, Oates JA, Sheller Jr. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994 149: 953 959.
8. 4 excretion. Am Rev Respir Dis 1993 147: 1472 1476.
9. Powell WS, Xu LJ, Martin JG. Effects of dexamethasone on leukotriene synthesis and airway responses to antigen and leukotriene D4 in rats. Am J Respir Crit Care Med 1995 151: 1143 1150.
10. Tanaka S, Tanaka H, Abe S. High dose of inhaled fluticasone reduced high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. Chest 2003 124: 1768 1773.
11. Overbeek SE, O'Sullivan S, Leman K, Mulder PGH, Hoogsteden HC, Prins J-B. Effect of montelukast compared with inhaled fluticasone on airway inflammation. Clin Exp Allergy 2004 34: 1388 1394.
12. Gyllfors P, Dahlen S-E, Kumlin M, Larsson K, Dahlen B. Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol 2006 118: 78 83.
13. Negri J, Early SB, Steinke JW, Borish L. Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways. J Allergy Clin Immunol 2008 121: 1232 1237.
14. National Institutes of Health. Global strategy for asthma management and prevention. NIH publication No. 02-3659 (updated 2008).
15. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010 40: 35 53.
16. Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D et al. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med 1994 149: 1447 1445.
17. Leigh R, Vethanayagam D, Yoshida M, Watson RM, Rerecich T, Inman MD et al. Effects of montelukast and budesonide on airway response and airway inflammation in asthma. Am J Respir Crit Care Med 2002 166: 1212 1217.
18. Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009 33: 1302 1308.
19. De Caterina R, Sicari R, Giannessi D, Paggiaro PL, Paoletti P, Lazzerini G et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 1993 75: 2368 2375.
20. Creticos PS. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists. Drugs 2003 63 (Suppl. 2 1 20.